{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T02:59:00Z","timestamp":1782010740985,"version":"3.54.5"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,3,10]],"date-time":"2020-03-10T00:00:00Z","timestamp":1583798400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81102707, 81972214, 81772932, 81472202, 81201535, 81302065, 81671716, 81301993, 81372175 and 81472209"],"award-info":[{"award-number":["81102707, 81972214, 81772932, 81472202, 81201535, 81302065, 81671716, 81301993, 81372175 and 81472209"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2020.00216","type":"journal-article","created":{"date-parts":[[2020,3,10]],"date-time":"2020-03-10T04:40:38Z","timestamp":1583815238000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":41,"title":["Hepatic Proteomic Changes and Sirt1\/AMPK Signaling Activation by Oxymatrine Treatment in Rats With Non-alcoholic Steatosis"],"prefix":"10.3389","volume":"11","author":[{"given":"Hong","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gao-Feng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Shui","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang-Hui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Ya","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Ping","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Hui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Mou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,3,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1080\/17460441.2016.1245286","article-title":"Recent advances in targeting the fatty acid biosynthetic pathway using fatty acid synthase inhibitors.","volume":"11","author":"Angeles","year":"2016","journal-title":"Expert Opin. Drug Discov."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.3748\/wjg.v19.i8.1158","article-title":"From fatty liver to fibrosis: a tale of \u201csecond hit\u201d.","volume":"19","author":"Basaranoglu","year":"2013","journal-title":"World J. Gastroenterol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD).","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism"},{"key":"B4","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1080\/03602532.2017.1293683","article-title":"Non-alcoholic fatty liver disease (NAFLD) -pathogenesis, classification, and effect on drugmetabolizing enzymes and transporters.","volume":"49","author":"Cobbina","year":"2017","journal-title":"Drug Metab. Rev."},{"key":"B5","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.tem.2017.05.004","article-title":"AMPK as a therapeutic target for treating metabolic diseases.","volume":"28","author":"Day","year":"2017","journal-title":"Trends Endocrinol. Metab."},{"key":"B6","doi-asserted-by":"publisher","first-page":"893","DOI":"10.5551\/jat.2055","article-title":"Expression of perilipin and adipophilin in nonalcoholic fatty liver disease; relevance to oxidative injury and hepatocyte ballooning.","volume":"16","author":"Fujii","year":"2009","journal-title":"J. Atheroscler. Thromb."},{"key":"B7","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/6491420","article-title":"A review of Western and traditional Chinese medical approaches to managing nonalcoholic fatty liver disease.","volume":"2016","author":"Hsu","year":"2016","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.jprot.2018.04.019","article-title":"Quantitative proteomics identify an association between extracellular matrix degradation and immunopathology of genotype VII Newcastle disease virus in the spleen in chickens.","volume":"181","author":"Hu","year":"2018","journal-title":"J. Proteomics"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.1021\/bi0352318","article-title":"Liver fatty acid-binding protein colocalizes with peroxisome proliferator activated receptor alpha and enhances ligand distribution to nuclei of living cells.","volume":"43","author":"Huang","year":"2004","journal-title":"Biochemistry"},{"key":"B10","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.bbalip.2011.09.017","article-title":"Fatty acid synthase and liver triglyceride metabolism: housekeeper or messenger?","volume":"1821","author":"Jensen-Urstad","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"B11","doi-asserted-by":"publisher","first-page":"12792","DOI":"10.18632\/oncotarget.12478","article-title":"Protective effects of oxymatrine against arsenic trioxide induced liver injury.","volume":"8","author":"Li","year":"2017","journal-title":"Oncotarget"},{"key":"B12","doi-asserted-by":"publisher","first-page":"24231","DOI":"10.1074\/jbc.m116.759795","article-title":"Perilipin-2 deletion impairs hepatic lipid accumulation by interfering with sterol regulatory element-binding protein (SREBP) activation and altering the hepatic lipidome.","volume":"291","author":"Libby","year":"2016","journal-title":"J. Biol. Chem."},{"key":"B13","doi-asserted-by":"publisher","first-page":"8325","DOI":"10.3748\/wjg.v20.i26.8325","article-title":"Proteomic and genomic studies of non-alcoholic fatty liver disease\u2013clues in the pathogenesis.","volume":"20","author":"Lim","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1159\/000493650","article-title":"Fisetin protects against hepatic steatosis through regulation of the Sirt1\/AMPK and fatty acid \u03b2-oxidation signaling pathway in high-fat diet-induced obese mice.","volume":"49","author":"Liou","year":"2018","journal-title":"Cell Physiol. Biochem."},{"key":"B15","doi-asserted-by":"publisher","first-page":"5136","DOI":"10.2174\/1381612823666170918120643","article-title":"Natural active compounds from plant food and Chinese herbal medicine for nonalcoholic fatty liver disease.","volume":"23","author":"Liu","year":"2017","journal-title":"Curr. Pharm. Des."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/pmic.201700267","article-title":"Differential proteomic analysis of dimethylnitrosamine (DMN)-induced liver fibrosis.","volume":"17","author":"Liu","year":"2017","journal-title":"Proteomics"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1002\/ptr.5632","article-title":"Potential signaling pathways involved in the clinical application of oxymatrine.","volume":"30","author":"Lu","year":"2016","journal-title":"Phytother. Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"G1053","DOI":"10.1152\/ajpgi.00116.2009","article-title":"Hepatic phenotype of liver fatty acid binding protein gene-ablated mice.","volume":"297","author":"Martin","year":"2009","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1194\/jlr.M077891","article-title":"Loss of fatty acid binding protein-1 alters the hepatic endocannabinoid system response to a high fat diet.","volume":"58","author":"Martin","year":"2017","journal-title":"J. Lipid Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"C728","DOI":"10.1152\/ajpcell.00448.2011","article-title":"Direct interaction of Plin2 with lipids on the surface of lipid droplets: a live cell FRET analysis.","volume":"303","author":"McIntosh","year":"2012","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1194\/jlr.M035063","article-title":"Perilipin-2-null mice are protected against diet-induced obesity, adipose inflammation, and fatty liver disease.","volume":"54","author":"McManaman","year":"2013","journal-title":"J. Lipid Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1002\/2211-5463.12240","article-title":"Silencing of FABP1 ameliorates hepatic steatosis, inflammation, and oxidative stress in mice with nonalcoholic fatty liver disease.","volume":"7","author":"Mukai","year":"2017","journal-title":"FEBS Open Biol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"G726","DOI":"10.1152\/ajpgi.00436.2015","article-title":"Liver-specific loss of Perilipin 2 alleviates diet-induced hepatic steatosis, inflammation, and fibrosis.","volume":"310","author":"Najt","year":"2016","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1002\/hep.21369","article-title":"Protection against Western diet-induced obesity and hepatic steatosis in liver fatty acid-binding protein knockout mice.","volume":"44","author":"Newberry","year":"2006","journal-title":"Hepatology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"384","DOI":"10.14218\/JCTH.2017.00013","article-title":"Non-alcoholic fatty liver disease: a clinical update.","volume":"5","author":"Pappachan","year":"2017","journal-title":"J. Clin. Transl. Hepatol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"33959","DOI":"10.1074\/jbc.M110.122978","article-title":"SIRT1 deacetylates and inhibits SREBP-1C activity in regulation of hepatic lipid metabolism.","volume":"285","author":"Ponugoti","year":"2010","journal-title":"J. Biol. Chem."},{"key":"B27","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.cmet.2009.02.006","article-title":"Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepaticsteatosis and inflammation.","volume":"9","author":"Purushotham","year":"2009","journal-title":"Cell Metab."},{"key":"B28","doi-asserted-by":"publisher","first-page":"439","DOI":"10.3892\/mmr.2013.1512","article-title":"Oxymatrine ameliorates non-alcoholic fatty liver disease in rats through peroxisome proliferator-activated receptor-\u03b1 activation.","volume":"8","author":"Shi","year":"2013","journal-title":"Mol. Med. Rep."},{"key":"B29","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ejphar.2013.06.013","article-title":"Oxymatrine attenuates hepatic steatosis in non-alcoholic fatty liver disease rats fed with high fructose diet through inhibition of sterol regulatory element binding transcription factor 1 (Srebf1) and activation of peroxisome proliferator activated receptor alpha (Ppar\u03b1).","volume":"714","author":"Shi","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"E730","DOI":"10.1152\/ajpendo.00225.2016","article-title":"Treatment of nonalcoholic fatty liver disease: role of AMPK.","volume":"311","author":"Smith","year":"2016","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1038\/nprot.2010.123","article-title":"Simultaneous analysis of relative protein expression levels across multiple samples using iTRAQ isobaric tags with 2D nano LC-MS\/MS.","volume":"5","author":"Unwin","year":"2010","journal-title":"Nat. Protoc."},{"key":"B32","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1194\/jlr.R056705","article-title":"Recent insights into the biological functions of liver fatty acid binding protein 1.","volume":"56","author":"Wang","year":"2015","journal-title":"J. Lipid Res."},{"key":"B33","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1073\/pnas.051619898","article-title":"Fatty acids and hypolipidemic drugs regulate peroxisome proliferator-activated receptors \u03b1- and \u03b3-mediated gene expression via liver fatty acid binding protein: a signaling path to the nucleus.","volume":"98","author":"Wolfrum","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/srep33386","article-title":"Association of non-alcoholic fatty liver disease with major adverse cardiovascular events: a systematic review and meta-analysis.","volume":"6","author":"Wu","year":"2016","journal-title":"Sci. Rep."},{"key":"B35","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1530\/JOE-15-0409","article-title":"Metformin improves hepatic IRS2\/PI3K\/Akt signaling in insulin-resistant rats of NASH and cirrhosis.","volume":"229","author":"Xu","year":"2016","journal-title":"J. Endocrinol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.jep.2017.09.016","article-title":"Isobaric tags for relative and absolute quantitation (iTRAQ)-based proteomics for the investigation of the effect of Hugan Qingzhi on non-alcoholic fatty liver disease in rat.","volume":"212","author":"Yao","year":"2018","journal-title":"J. Ethnopharmacol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cld.2017.08.001","article-title":"Clinical and economic burden of nonalcoholic fatty Liver disease and nonalcoholic steatohepatitis.","volume":"22","author":"Younossi","year":"2018","journal-title":"Clin. Liver Dis."},{"key":"B38","doi-asserted-by":"publisher","first-page":"2446","DOI":"10.1021\/acs.jproteome.8b00951","article-title":"Proteomic profiling for metabolic pathways involved in interactive effects of elevated carbon dioxide and nitrogen on leaf growth in a perennial grass species.","volume":"18","author":"Yu","year":"2019","journal-title":"J. Proteome Res."},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.01459","article-title":"Herbal extracts and natural products in alleviating non-alcoholic fatty liver disease via activating autophagy.","volume":"9","author":"Zhang","year":"2018","journal-title":"Front. Pharmacol."},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-15141-x","article-title":"MicroRNA-27a regulates hepatic lipid metabolism and alleviates NAFLD via repressing FAS and SCD1.","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci. Rep."},{"key":"B41","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.molmet.2016.11.002","article-title":"Celastrol ameliorates liver metabolic damage caused by a high-fat diet through Sirt1.","volume":"6","author":"Zhang","year":"2016","journal-title":"Mol. Metab."},{"key":"B42","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.intimp.2016.04.040","article-title":"Oxymatrine attenuates CCl4-induced hepatic fibrosis via modulation of TLR4-dependent inflammatory and TGF-\u03b21 signaling pathways.","volume":"36","author":"Zhao","year":"2016","journal-title":"Int. Immunopharmacol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2020.00216\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,10]],"date-time":"2020-03-10T04:40:40Z","timestamp":1583815240000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2020.00216\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,10]]},"references-count":42,"alternative-id":["10.3389\/fphar.2020.00216"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2020.00216","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,10]]},"article-number":"216"}}